Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use
Forecasted Federal grant Posted
- Opportunity number
- CDC-RFA-PS-27-0239
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications expected due
- Award size
- Not on record
Opportunity facts
- Expected posting
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- For Profit Organizations
- 501(c)(3) Nonprofits
- City/Township Governments
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Public)
- Non-501(c)(3) Nonprofits
- Independent School Districts
- Unrestricted
- Public or Indian Housing Auth.
- Tribal Organizations (Not Federally Recognized)
- Special District Governments
- County Governments
- Small Businesses
- State Governments
- Higher Education Inst. (Private)
- Points of contact
-
- Monica Adams ydy7@cdc.gov (404) 718-5092
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention is soliciting applications for a cooperative agreement to strengthen services preventing infectious disease consequences of drug use in high-impact settings serving people who use drugs, under CFDA 93.488 (National Harm Reduction Technical Assistance and Syringe Services Program Monitoring and Evaluation Funding Opportunity); the source does not specify an application due date.
Eligible applicants include for-profit organizations, 501(c)(3) and non-501(c)(3) nonprofits, state and local governments, tribal governments (federally recognized and non-federally recognized tribal organizations), public and private higher education institutions, small businesses, independent school districts, special district governments, and public or Indian housing authorities. The recipient must perform a substantial role in project execution and cannot serve merely as a conduit to another eligible party.
Applicants may apply for Component 1 (biennial surveys of high-impact settings to document capacity, needs, access, and service gaps; biobehavioral surveys of people who use drugs to assess infectious disease testing, treatment, and prevention service use), Component 2 (increasing availability and use of infectious disease testing, treatment, and prevention services in high-impact settings), or both components. Funding may support costs associated with media analysis and content development, monitoring and evaluation implementation, and capacity strengthening; recipients may not use funding for furniture or equipment purchases except where specifically identified and approved in the budget.
The cooperative agreement period of performance extends from one to five years, with initial awards funding the first 12-month budget period. After initial awards, projects may continue non-competitively contingent on satisfactory progress and federal funding availability. Expected outcomes include enhanced national and local capacity to improve infectious disease testing, treatment, and prevention services, and increased testing and treatment initiation among people who use drugs for hepatitis B, hepatitis C, and HIV.
Forecast synopsis
This NOFO aims to strengthen services to prevent the infectious disease consequences of drug use in high impact settings serving people who use drugs (PWUD) through two components. Component 1 will improve service data by conducting a biennial survey of high-impact settings that serve PWUD to document capacity, needs, access, and service gaps. It will also improve timely local data on infectious disease consequences of drug use and the use of infectious disease testing, treatment, and prevention services at high-impact settings through a biennial biobehavioral survey of PWUD. Component 2 will increase support the availability and use of infectious disease testing, treatment and prevention services in high-impact settings serving PWUD. Applicants may apply for Component 1, Component 2, or both. Expected outcomes include enhanced capacity nationally and locally to use data to improve infectious disease testing, treatment and prevention services among PWUD, increased PWUD testing for HBV, HCV, and HIV, increased PWUD with hepatitis C who initiated treatment, and increased PWUD with HIV who engaged in care and treatment. This NOFO is in alignment with CDC priorities.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity